1,821
Views
2
CrossRef citations to date
0
Altmetric
Articles

Comparison between radiofrequency ablation combined with mifepristone and radiofrequency ablation for large uterine fibroids

ORCID Icon, , &
Pages 777-780 | Received 29 Jan 2021, Accepted 21 Apr 2021, Published online: 12 May 2021

References

  • Baird DD, Dunson DB, Hill MC, Cousins D, et al. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188(1):100–107.
  • Rey VE, Labrador R, Falcon M, et al. Transvaginal radiofrequency ablation of myomas: technique, outcomes, and complications. J Laparoendosc Adv Surg Tech A. 2019;29(1):24–28.
  • Iversen H, Dueholm M. Radiofrequency thermal ablation for uterine myomas: long-term clinical outcomes and reinterventions. J Minim Invasive Gynecol. 2017;24(6):1020–1028.
  • Yin G, Chen M, Yang S, et al. Treatment of uterine myomas by radiofrequency thermal ablation: a 10-year retrospective cohort study. Reprod Sci. 2015;22(5):609–614.
  • Garza-Leal JG. Long-term clinical outcomes of transcervical radiofrequency ablation of uterine fibroids: the VITALITY study. J Gynecol Surg. 2019;35(1):19–23.
  • Brölmann H, Bongers M, Garza-Leal JG, et al. The FAST-EU trial: 12-month clinical outcomes of women after intrauterine sonography-guided transcervical radiofrequency ablation of uterine fibroids. Gynecol Surg. 2016;13(1):27–35.
  • Carrafiello G, Recaldini C, Fontana F, et al. Ultrasound-guided radiofrequency thermal ablation of uterine fibroids: medium-term follow-up. Cardiovasc Intervent Radiol. 2010;33(1):113–119.
  • Cho HH, Kim JH, Kim MR. Transvaginal radiofrequency thermal ablation: a day-care approach to symptomatic uterine myomas. Aust N Z J Obstet Gynaecol. 2008;48(3):296–301.
  • Jiang X, Thapa A, Lu J, et al. Ultrasound-guided transvaginal radiofrequency myolysis for symptomatic uterine myomas. Eur J Obstet Gynecol Reprod Biol. 2014;177:38–43.
  • Kim CH, Kim SR, Lee HA, et al. Transvaginal ultrasound-guided radiofrequency myolysis for uterine myomas. Hum Reprod. 2011;26(3):559–563.
  • Kettel LM, Murphy AA, Morales AJ, et al. Clinical efficacy of the antiprogesterone RU486 in the treatment of endometriosis and uterine fibroids. Hum Reprod. 1994;9(1):116–120.
  • Shen Q, Hua Y, Jiang W, et al. Effects of mifepristone on uterine leiomyoma in premenopausal women: a meta-analysis. Fertil Steril. 2013;100(6):1722.
  • Murji A, Whitaker L, Chow TL, et al. Selective progesterone receptor modulators (SPRMs) for uterine fibroids. Cochrane Database Syst Rev. 2017; 4(4):CD010770.
  • Reinsch RC, Murphy AA, Morales AJ, et al. The effects of RU 486 and leuprolide acetate on uterine artery blood flow in the fibroid uterus: a prospective, randomized study. Am J Obstet Gynecol. 1994;170(6):1623–1627.
  • Guidance for Industry. Drug-induced liver injury: premarketting clinical evaluation. Washington (DC): US Department of Health and Human Services; 2009.
  • Hai N, Hou Q, Ding X, et al. Ultrasound-guided transcervical radiofrequency ablation for symptomatic uterine adenomyosis. Br J Radiol. 2017;90(1069):20160119.
  • Spies JB, Coyne K, Guaou Guaou N, et al. The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata. Obstet Gynecol. 2002;99(2):290–300.
  • Lee BB, Yu SP. Radiofrequency ablation of uterine fibroids: a review. Curr Obstet Gynecol Rep. 2016;5(4):318–324.
  • Goldberg SN. Radiofrequency tumor ablation: principles and techniques. Eur J Ultrasound. 2001;13(2):129–147.
  • Liu H, Zhang J, Han ZY, et al. Effectiveness of ultrasound-guided percutaneous microwave ablation for symptomatic uterine fibroids: a multicentre study in China. Int J Hyperthermia. 2016;32(8):876–880.
  • Moshesh M, Peddada SD, Cooper T, et al. Intraobserver variability in fibroid size measurements: estimated effects on assessing fibroid growth. J Ultrasound Med. 2014;33(7):1217–1224.
  • Dueholm M, Lundorf E, Hansen ES, et al. Accuracy of magnetic resonance imaging and transvaginal ultrasonography in the diagnosis, mapping, and measurement of uterine myomas. Am J Obstet Gynecol. 2002;186(3):409–415.